Vitlife

PHASE 2B TRIAL OF REPIBRESIB GEL IN NONSEGMENTAL VITILIGO ENDS EARLY

Share this article →
 
 
Close

Search articles

Phase 2b Trial of Repibresib Gel in Nonsegmental Vitiligo Ends Early

 Posted on 19th August 2025  2 minute read

Sorry, but you do not have permission to view this content.

Please support our work! You've enjoyed 2 articles this month and we hope you have found them useful. Our work is entirely funded by memberships and donations, so please consider joining our charity today and supporting our work.

Become a Member